Harald Sauer1, Stefan Graeber2, Ulla Lieser3, Juergen Foell4. 1. Clinic for Pediatric Cardiology, University Hospital of Saarland, 66421, Homburg, Germany. harald.sauer@uks.eu. 2. Institute of Medical Biometry, Epidemiology and Medical Computer Science, University Hospital of Saarland, Kirrberger Straße, Homburg (Saar), Germany. 3. Clinic for Pediatrics and Adolescent Medicine, Helios Hospital Leisnig, Leisnig, Germany. 4. Hospital for Pediatrics and Adolescent Medicine, University Hospital Regensburg, Regensburg, Germany.
Abstract
BACKGROUND: Nearly all paediatric patients require deep sedation when undergoing bone marrow aspiration (BMA). We analyzed the data from our protocols documented in a standardised procedure for bone marrow puncture over a period of 2 years. METHODS: Our standard included the documentation of personal data as well as vital parameters. In addition, we documented all medications administered, potential complications and required intervention measures, as necessary. RESULTS: A total of 107 protocols were available for the evaluation. Our standard covered the usage of midazolam and S‑ketamine and resulted in complications in just 9 patients, which could be remedied using simple measures. For both active substances, the dosage necessary to reach sufficient deep analgosedation was significantly higher for patients under 24 months of age. CONCLUSIONS: Our standard for BMA provides a practical and feasible procedure. In addition to good examination conditions, our standard also helps ensure the safety of our patients.
BACKGROUND: Nearly all paediatric patients require deep sedation when undergoing bone marrow aspiration (BMA). We analyzed the data from our protocols documented in a standardised procedure for bone marrow puncture over a period of 2 years. METHODS: Our standard included the documentation of personal data as well as vital parameters. In addition, we documented all medications administered, potential complications and required intervention measures, as necessary. RESULTS: A total of 107 protocols were available for the evaluation. Our standard covered the usage of midazolam and S‑ketamine and resulted in complications in just 9 patients, which could be remedied using simple measures. For both active substances, the dosage necessary to reach sufficient deep analgosedation was significantly higher for patients under 24 months of age. CONCLUSIONS: Our standard for BMA provides a practical and feasible procedure. In addition to good examination conditions, our standard also helps ensure the safety of our patients.
Entities:
Keywords:
Analgosedation; Bone marrow aspiration; Paediatric patients; Sedation; Standard
Authors: Paulo Sérgio Lucas da Silva; Vânia Euzébio de Aguiar; Daniel Reis Waisberg; Roselene M Augusto Passos; Miriam Verônica Flor Park Journal: Pediatr Int Date: 2011-02 Impact factor: 1.524